Showing results (81-90 of 182) with videos related to

Sort By:
Pageof 19
Anticancer Research|June 25, 2003
Prognostic significance of expression of p53 oncoprotein in primary (stage I-IIIa) non-small cell lung cancerDong-Feng Tan, Qiang Li, Nithya Rammath, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 19, 2008
The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomesSuzanne C O'Neill, Della Brown White, Saskia C Sanderson, et al.
Cancer Research|January 21, 2015
β-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transitionSmitha Pillai, Jose Trevino, Bhupendra Rawal, et al.
Plos One|September 8, 2012
Depletion of HDAC6 enhances cisplatin-induced DNA damage and apoptosis in non-small cell lung cancer cellsLei Wang, Shengyan Xiang, Kendra A Williams, et al.
The Journal of the Association of Physicians of India|July 21, 2019
Effects of Canagliflozin on Abnormal Liver Function Tests in Patients of Type 2 Diabetes with Non-Alcoholic Fatty Liver DiseaseAshish Gautam, Prabhat Kumar Agrawal, Jitender Doneria, et al.
The Journal of the Association of Physicians of India|July 21, 2019
Teneligliptin: An Economic and Effective DPP-4 Inhibitor for the Management of Type-2 Diabetes Mellitus: A Comparative StudyPrabhat Agrawal, Ashish Gautam, Nikhil Pursnani, et al.
Cancer|October 16, 2012
Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokersJhanelle E Gray, Soner Altiok, Mark G Alexandrow, et al.
Molecular and Cellular Biology|May 25, 2011
ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signalingSmitha Pillai, Wasia Rizwani, Xueli Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinomaValsamo K Anagnostou, Gerold Bepler, Konstantinos N Syrigos, et al.
Oncotarget|September 22, 2016
Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cellsSanjeevani Arora, Joshua Heyza, Hao Zhang, et al.
Pageof 19